In March, the World Health Organization (WHO) launched the coordinated "Solidarity Trial" in 10 countries to rapidly assess in thousands of patients infected with COVID-19 the potential efficacy of antiviral agents and existing anti-inflammatories that have not yet been specifically evaluated for COVID-19.
Mwezi wa Machi, Shirika la Afya Duniani (WHO) lilizindua &quot;jaribio la umoja&quot; ulioratibiwa katika nchi 10 ili kukagua haraka maelfu ya watu walioambikizwa na COVID-19, ufanisi unaowezekana wa dawa za kuzuia virusi au kuzuia uvimbe ambazo bado hazijakaguliwa kwa ajili ya ugonjwa wa COVID-19.